Get our latest issue now
available for iOS, Android & web
Friday, March 6, 2015
News
Daily News
Free news headlines
Free RSS feed
Reprints
Magazine
Overview
Latest Issue
Business Insights
Subscribe
Have your say
Advertising with PharmaTimes
Media Info
Features Calendar for 2015
Reprints
NHS Payers
Visions
Medical Communications
JobSearch
Find a job
Latest People
List a vacancy online
Get jobs by email
Manage job postings
Recruiter directory
Rates
Contacts
Competitions
Clinical Researcher
Communications Team
Marketer
Medical Science Liaison
Partnerships In Health Awards
Sales Awards
US Clinical Researcher
Events/Meetings
Partnerships In Health Networking
PharmaTimes Directors' Club
PharmaTimes Webinars
SOPHIE
Reports
Overview
Contents
Order Form
Gallery
Advertise
Subscribe
Contact
Daily News
Free news headlines
Free RSS feed
Where am I? >
Home
No news feed available, please enable Javascript.
Gates Foundation sinks $52m into CureVac
...more Daily News
AbbVie buys Pharmacyclics for $21bn
...more Daily News
Mallinckrodt buys Ikaria for $2.3bn
...more Daily News
Rapid US approval for BMS' Opdivo in lung cancer
...more Daily News
BMS signs $975m deal with Bavarian Nordic
...more Daily News
MPs slam NHS 'institutional bias' against mental health
...more Daily News
Eisai and Merck in cancer combo deal
...more Daily News
FDA launches app for drug shortages
...more Daily News
Baxter buys Germany's SuppreMol
...more Daily News
Latest Jobs
Find a job
What's happening at PharmaTimes?
Click here to see the latest issue
of PharmaTimes Magazine
View our free on-demand webinar – doctors, pharma and the future of healthcare
Get your free PharmaTimes subscription here
More News
AbbVie buys Pharmacyclics for $21bn
Gates Foundation sinks $52m into CureVac
Mallinckrodt buys Ikaria for $2.3bn
Rapid US approval for BMS' Opdivo in lung cancer
BMS signs $975m deal with Bavarian Nordic
MPs slam NHS 'institutional bias' against mental health
Eisai and Merck in cancer combo deal
FDA launches app for drug shortages
Baxter buys Germany's SuppreMol
Website Search
Search
Search
Business Insight
Takeda aims for best in class
Click here to read the full story
Competitions News
International CROY 2015 finalists are announced
Read more here
Most Read
Most read articles
BI files Pradaxa antidote in US, EU and Canada
AZ, Cambridge Uni link to support biotech start-ups
What does disclosure mean for the UK? We ask the ABPI
Eisai and Merck in cancer combo deal
Rapid US approval for BMS' Opdivo in lung cancer
Latest Jobs
Popular Tags
Twitter
YouTube
Tweets by @PharmaTimes